Last update:

Clinical pharmacology news

One inhibitor, opposite outcome: How a double-target effect could reshape ferroptosis therapies

Switching off an enzyme that plays an important role in sugar metabolism, glycolysis, would normally be expected to cause serious problems for cells. Surprisingly, the opposite is also true: Cells can become highly resistant ...

Tezepelumab helps severe asthma patients reduce oral steroids over 28 weeks

New results from the Phase III SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral corticosteroid use in adults with severe oral corticosteroid-dependent asthma while maintaining ...